Vertex’s clinical trials mark a step toward finding treatments for pain without addiction risks.
The company’s client was Purdue Pharma, the Connecticut drugmaker accused in lawsuits of helping ignite the epidemic through aggressive marketing and sales of OxyContin.
Purdue Pharma is the pharmaceutical company that manufactures OxyContin, the most popular opioid painkiller in America and the backbone of Purdue’s business. According to a ProPublica dive into ...
For the first time, an advertising company that worked on Purdue Pharma’s OxyContin account has settled a lawsuit that accused it of falsely marketing opioids as safe. Publicis, a French ...
The Boy Scouts of America on Thursday asked the U.S. Supreme Court to allow the youth organization to proceed with a $2.46 ...
PARIS -- A unit of French advertising giant Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioid epidemic in the United ...
Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioids epidemic in the United States. Oregon officials declared a 90-day ...
and some people have profited enormously from the suffering of chronic pain patients: Can a $6 billion bankruptcy settlement cleanse Purdue Pharma and the Sacklers of their transgressions and give ...
See Lujan Claimants et al. v. Boy Scouts of America et al, Case No. 23A741. Taken in tandem with the Court’s review of the Chapter 11 plan of Purdue Pharma (see In re Purdue Pharma L.P., 69 F.4th 45 ...
A unit of French advertising giant Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioid epidemic in the United States.